Techno Medica Co., Ltd. (TYO:6678)
Japan · Delayed Price · Currency is JPY 1,936.00
-11.00 (-0.56%)
Aug 13, 2025, 3:30 PM JST
Paramount Global Revenue
Techno Medica had revenue of 1.76B JPY in the quarter ending June 30, 2025, a decrease of -12.11%. This brings the company's revenue in the last twelve months to 9.66B, down -8.07% year-over-year. In the fiscal year ending March 31, 2025, Techno Medica had annual revenue of 9.91B, down -3.68%.
Revenue (ttm)
9.66B
Revenue Growth
-8.07%
P/S Ratio
1.39
Revenue / Employee
39.60M
Employees
244
Market Cap
13.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 9.91B | -378.00M | -3.68% |
| Mar 31, 2024 | 10.28B | 916.00M | 9.78% |
| Mar 31, 2023 | 9.37B | -332.00M | -3.42% |
| Mar 31, 2022 | 9.70B | 659.00M | 7.29% |
| Mar 31, 2021 | 9.04B | -770.00M | -7.85% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |